(Q42088229)

16 October 2017

title

3-O-methyldopa uptake and inhibition of L-dopa at the blood-brain barrier (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1143006

26 August 2022

3-0-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrier (English)

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

13 October 2023

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1143006

26 August 2022

author name string

L. A. Wade

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1143006

26 August 2022

R. Katzman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1143006

26 August 2022

language of work or name

English

0 references

publication date

1 July 1975

1 reference

full work available at URL

16 October 2017

https://api.elsevier.com/content/article/PII:0024320575902489?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

https://api.elsevier.com/content/article/PII:0024320575902489?httpAccept=text/plain

13 October 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

13 October 2023

1 reference

16 October 2017

volume

17

1 reference

16 October 2017

issue

1

1 reference

16 October 2017

page(s)

131-136

1 reference

Drug-Induced Changes of Extracerebral Dopa Metabolism in Man

16 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

The metabolism of L-3-0-methyldopa, aprecursor of dopa in man

13 October 2023

2

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

Distribution and metabolism of l-3-O-methyldopa in rats

13 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

l-DOPA treatment in Parkinson's disease: Effect on dopamine and related substances in discrete brain regions

13 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

Dopa and 3-O-methyldopa in cerebrospinal fluid of parkinsonism patients during treatment with oral l-dopa

13 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine

13 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

Regional distribution of catecholamines in rat brain after L-3-O-methyldopa and L-dopa.

13 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection

13 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

Rat brain regional uptake and decarboxylation of L-DOPA following carotid injection

13 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

13 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

Brain blood flow in the conscious and anesthetized rat

13 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients

13 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

3-Methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's disease

13 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

A comparison of the transport systems for amino acids in brain, intestine, kidney and tumour

13 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

Advances in biochemical psychopharmacology

13 October 2023

21

4

39

Christensen

1972

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

Brain Serotonin Content: Physiological Regulation by Plasma Neutral Amino Acids

13 October 2023

23

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

13 October 2023

Pharmacological Reviews

27

18

369

Bertler

1966

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

Dopamine formation in brain capillaries--an enzymic blood-brain barrier mechanism

13 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

Plasma dopa concentrations and the "on-off" effect after chronic treatment of Parkinson's disease

13 October 2023

30

1 reference

https://api.crossref.org/works/10.1016/0024-3205(75)90248-9

13 October 2023

Identifiers

1 reference

16 October 2017

1 reference